Tojimbara, T <br/><br/>
Cyclosporine-sparing effect of basiliximab in renal transplant recipients with mycophenolate mofetil.  [electronic resource] 

 -  Transplantation proceedings  Mar 2005 
 - 895-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2004.12.173  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Basiliximab<br/>Cyclosporine--therapeutic use<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Graft Rejection--epidemiology<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Transplantation--immunology<br/>Methylprednisolone--therapeutic use<br/>Mycophenolic Acid--analogs & derivatives<br/>Recombinant Fusion Proteins--therapeutic use